Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods
Caroline E. Strong, Mohamed Kabbaj
Neurobiology of Stress (2018) Vol. 9, pp. 166-175
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 161
Fighting Females: Neural and Behavioral Consequences of Social Defeat Stress in Female Mice
Emily L. Newman, Herbert E. Covington, Junghyup Suh, et al.
Biological Psychiatry (2019) Vol. 86, Iss. 9, pp. 657-668
Open Access | Times Cited: 150
A historical review of antidepressant effects of ketamine and its enantiomers
Wei Yan, Lijia Chang, Kenji Hashimoto
Pharmacology Biochemistry and Behavior (2020) Vol. 190, pp. 172870-172870
Open Access | Times Cited: 140
Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice
Radhika Rawat, Elif Tunc‐Ozcan, Tammy L. McGuire, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression
Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, et al.
Psychoactives (2024) Vol. 3, Iss. 2, pp. 215-234
Open Access | Times Cited: 9
The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial
Richard J. Zeifman, Fernanda Palhano-Fontes, Jaime E. C. Hallak, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 63
Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder
Richard J. Zeifman, Anne Catherine Wagner
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 1-11
Closed Access | Times Cited: 60
The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences
Samuel J. Millard, Katrina Weston‐Green, Kelly A. Newell
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 101, pp. 109908-109908
Closed Access | Times Cited: 51
Ketamine’s rapid and sustained antidepressant effects are driven by distinct mechanisms
Radhika Rawat, Elif Tunc‐Ozcan, Sara Dunlop, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 6
Use and abuse of dissociative and psychedelic drugs in adolescence
M.L. Shawn Bates, Keith A. Trujillo
Pharmacology Biochemistry and Behavior (2021) Vol. 203, pp. 173129-173129
Open Access | Times Cited: 40
Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis
Simon Zhornitsky, Valérie Tourjman, Julie Pelletier, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 118, pp. 110575-110575
Closed Access | Times Cited: 23
Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus
Mohammed E. A. Elhussiny, Giulia Carini, Jessica Mingardi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110033-110033
Open Access | Times Cited: 35
Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective
Sandra Ledesma‐Corvi, Elena Hernández‐Hernández, M. Julia García‐Fuster
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction
Emilija Glavonic, Miloš Mitić, Miroslav Adžić
Journal of Neuroscience Research (2022) Vol. 100, Iss. 4, pp. 947-969
Closed Access | Times Cited: 16
Sex-dependent changes in ketamine-induced locomotor activity and ketamine pharmacokinetics in preweanling, adolescent, and adult rats
Sanders A. McDougall, Ginny I. Park, Goretti I. Ramirez, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 6, pp. 740-755
Open Access | Times Cited: 26
Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
Enrico Capuzzi, Alice Caldiroli, Martina Capellazzi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9338-9338
Open Access | Times Cited: 22
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Ezio Carboni, Anna R. Carta, E. Carboni, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 19
A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801
Patrick J. Morris, Richard Burke, Alok Sharma, et al.
Neurotoxicology and Teratology (2021) Vol. 87, pp. 106993-106993
Open Access | Times Cited: 17
Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice
Shao‐Tsu Chen, Chung-Pin Hsieh, Mei-Yi Lee, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112369-112369
Open Access | Times Cited: 17
Depression in Adolescence and Brain-Derived Neurotrophic Factor
Boyoung Lee, Eunjin Shin, Inwoong Song, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 12
Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants
Birgit Derntl, Jonas Hornung, Zümrüt Duygu Şen, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 18
(R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequency
Lace M. Riggs, Xiaoxian An, Edna F. R. Pereira, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Neural Mechanisms Underlying the Rewarding and Therapeutic Effects of Ketamine as a Treatment for Alcohol Use Disorder
Caroline E. Strong, Mohamed Kabbaj
Frontiers in Behavioral Neuroscience (2020) Vol. 14
Open Access | Times Cited: 15
The Ketamine Antidepressant Story: New Insights
Tahani K. Alshammari
Molecules (2020) Vol. 25, Iss. 23, pp. 5777-5777
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top